A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Clinical trial NCT07288203 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07288203
- Sponsor
- Iovance Biotherapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-28
- Primary completion
- 2032-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.